Hi Chook,
I have thought about Acadia side of the deal lately. Can anyone who has a model setup punch Acadia rough figures in.
I see our side produces some very high numbers, but theirs would be even higher, minus more costs obviously. In a market that values bio's apparently much better than ours, it's hard to see why they are still in the red post FDA approval.
Hi Chook,I have thought about Acadia side of the deal lately....
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
0.560(2.90%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| $19.80 | $20.00 | $19.40 | $3.777M | 191.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1060 | $19.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.87 | 209 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |